-
December 31, 2021 Psychedelic Business Spotlight – December 31This week in psychedelic business news: Mindset Pharma files another patent for compounds with "perfect...
-
December 29, 2021 Texas Further Embraces Psychedelics with Launch of Center for Psychedelic Research and TherapyResearch will focus on how various psychedelics can be used under proper supervision and guidance...
-
December 28, 2021 Ketamine Rapidly Reduces Depression, According to ‘Most Comprehensive Review’ of Evidence — But Patient Experiences Suggest More ApplicationsPsychedelic Spotlight speaks to a Field Trip Health patient and a psychotherapist, whose experiences suggest...
-
December 23, 2021 FDA Green Lights Tryp Therapeutics’ Psilocybin Study on Binge Eating DisorderThe pharmaceutical company developing psilocybin-based compounds for diseases with unmet medical needs estimates a $2.9...
-
December 21, 2021 A Second Washington City Approves Decriminalizing PsychedelicsThe psychedelic movement keeps on moving in the Pacific Northwest following Seattle's decriminalization resolution passing...
-
December 16, 2021 Australia Rejects Bid to Reschedule Psilocybin, MDMA for Therapeutic UseMind Medicine Australia, a psychedelics advocacy organization that filed the application, says the country "lost...
-
December 13, 2021 Compass Pathways Study Finds SSRI Drugs Did Not Impede Psilocybin’s Therapeutic EffectChief Medical Officer Guy Goodwin calls study "a strong signal that COMP360 psilocybin therapy could...
-
December 1, 2021 Why It’s Smart to Put Down Your Phone and Start Journaling InsteadJournaling is a key practice for integrating psychedelic experiences into our everyday lives, but it’s...
-
November 24, 2021 How the COVID Pandemic Inspired Wakeful Travel’s Psychedelic Integration JournalsA travel journal company pivots from external trips to those unfolding in the mind, and...
-
November 22, 2021 Jon Stewart ‘Would Love’ to Try Microdosing PsychedelicsThe comedian publicly expresses interest in the mental health treatment trend the same day as...
